MedTrace Logo

Paediatric Safety Study in Cat-PAD

NCT01921257 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-05-14

Study results available
· View outcomes & findings →

Summary

Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects

Conditions

  • Rhinoconjunctivitis

Interventions

DRUG

Cat-PAD

DRUG

Placebo

Sponsors & Collaborators

  • inVentiv Health Clinical

    collaborator OTHER

  • Circassia Limited

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01921257 on ClinicalTrials.gov